Dabrafenib Mesylate | 1195768-06-9 | Inhibitors

Dabrafenib Mesylate

Dabrafenib Mesylate
CAT No. CS-T-73270
Category Inhibitors
CAS 1195768-06-9
Storage Hygroscopic, -20°C Freezer, Under inert atmosphere
Application Dabrafenib is an inhibitor of mutated BRAF kinase and has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma.
Mol. Weight 615.67 g/mol
Formula C24H24F3N5O5S3
Stock Status For Exact delivery date, please contact sales@clearsynth.com
Synonyms GSK 2118436 Methanesulfonate Salt; GSK 2118436B; N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide Methanesulfonate
Documents COA   MSDS

Info related to delivery in Country: US

TAX: Taxes not applicable in your country.
Custom: Custom duty may be applicable at your country's local port.
Shipping: Shipping is Free.
Bank: 50$ Bank Charges applicable.

Need a Quick Quote?


Qty / Message*

You can also view some of our most viewed compounds

This product can be served promptly from: USA, Canada, Brazil, Russia, China, Middle East , Europe and India

This page containts information about: Dabrafenib Mesylate,Inhibitors,CAS 1195768-06-9, COA of Dabrafenib Mesylate, MSDS of Dabrafenib Mesylate



Your Query